Evidence map›Paper›PMID 34145643›Full record

ArticleJournal of the European Academy of Dermatology and Venereology : JEADV2021

Describing the burden of the COVID-19 pandemic in people with psoriasis: findings from a global cross-sectional study.

S K Mahil, M Yates, Z Z N Yiu, S M Langan, T Tsakok, N Dand, K J Mason, H McAteer, F Meynell, B Coker and 28 more

Abstract readLetter
In one paragraph

Article in Journal of the European Academy of Dermatology and Venereology : JEADV, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. The Role of Teledermatology During the COVID-19 Pandemic: A Narrative Review.Clinical, cosmetic and investigational dermatology · 2022
    Review
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

38 authors.

S K MahilSt John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.ORCID https://orcid.org/0000-0003-4692-3794
M YatesNIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.ORCID https://orcid.org/0000-0001-5449-5211
Z Z N YiuDermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, UK.ORCID https://orcid.org/0000-0002-1831-074X
S M LanganSt John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
T TsakokSt John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
N DandDepartment of Medical and Molecular Genetics, School of Basic and Medical Biosciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
K J MasonCentre for Rheumatic Diseases, King's College London, London, UK.ORCID https://orcid.org/0000-0002-5419-0669
H McAteerThe Psoriasis Association, Northampton, UK.
F MeynellSt John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
B CokerNIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
A VincentNIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
D UrmstonThe Psoriasis Association, Northampton, UK.
A VestyThe Psoriasis Association, Northampton, UK.
J KellyDermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, UK.
C LancelotInternational Federation of Psoriasis Associations (IFPA), Bromma, Sweden.
L MoorheadSt John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
H BachelezDepartment of Dermatology, AP-HP Hôpital Saint-Louis, Paris, France.
F CaponNIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
C R ContrerasCatedra de Dermatologia, Hospital de Clinicas, Facultad de Ciencias Medicas, Universidad Nacional de Asuncion, San Lorenzo, Paraguay.
C De La CruzClinica Dermacross, Santiago, Chile.
P Di MeglioNIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
P GisondiSection of Dermatology and Venereology, University of Verona, Verona, Italy.
D JullienDepartment of Dermatology, Edouard Herriot Hospital, Hospices Civils de Lyon, University of Lyon, Lyon, France.
J LambertDepartment of Dermatology, Ghent University, Ghent, Belgium.
L NaldiCentro Studi GISED, Bergamo, Italy.
S NortonPsychology Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
L PuigDepartment of Dermatology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
P SpulsDepartment of Dermatology, Amsterdam Public Health/Infection and Immunology, Amsterdam University Medical Centers, Location AMC, Amsterdam, The Netherlands.
T TorresDepartment of Dermatology, Centro Hospitalar do Porto, Porto, Portugal.
R B WarrenDermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, UK.
H WaweruInternational Federation of Psoriasis Associations (IFPA), Bromma, Sweden.
J WeinmanSchool of Cancer and Pharmaceutical Sciences, King's College London, London, UK.
M A BrownNIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
J B GallowayCentre for Rheumatic Diseases, King's College London, London, UK.
C M GriffithsDermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, UK.ORCID https://orcid.org/0000-0001-5371-4427
J N BarkerNIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
C H SmithSt John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.ORCID https://orcid.org/0000-0001-9918-1144
PsoProtect study group

Funding

Medical Research Council MR/S003126/1Medical Research Council MR/T02383X/1NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College LondonWellcome Trust 205039/Z/16/Z
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19PsoriasisCross-Sectional StudiesHumansPandemicsSARS-CoV-2

Identifiers

PMID34145643
PMCPMC8447018

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.